Annotation Detail

Information
Associated Genes
DNMT3A
Associated Variants
DNMT3A R882
DNMT3A R882
Associated Disease
acute myeloid leukemia
Source Database
CIViC Evidence
Description
In a large cohort of young AML patients (18-60 years old), DNMT3A R882 mutations were associated with reduced relapse free survival in the entire cohort as well as the subset of patients with cytogenetically normal AML.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/61
Gene URL
https://civic.genome.wustl.edu/links/genes/18
Variant URL
https://civic.genome.wustl.edu/links/variants/32
Rating
3
Evidence Type
Prognostic
Disease
Acute Myeloid Leukemia
Evidence Direction
Supports
Evidence Level
A
Clinical Significance
Poor Outcome
Pubmed
23632886
Drugs